Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

TAK-279 effectively reduces psoriasis symptoms and is safe.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Finasteride is a medicine used to treat enlarged prostate and prostate cancer, and it works by changing how testosterone works in the body.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.